Guide for applicants: PCT procedure before the EPO (Euro-PCT Guide)

any amendments made to the claims under Article 19 PCT in the form of a translation of the complete set of claims furnished in replacement of all claims originally filed (see point 3.2.033), but only if the applicant wishes these amendments to form the basis of further proceedings. The claims as amended under Article 19 PCT must be submitted together with, if submitted to the IB, the translated statement under Article 19(1) PCT explaining the amendments and the translated accompanying letter under Rule 46.5(b) PCT, indicating the basis for the amendments in the application as filed, in an official language of the EPO, so as to allow the examiner to understand and take the amendments into account. If a translation of the complete set of claims submitted under Article 19 PCT is not furnished or not accompanied by a translation of, if submitted to the IB, the statement under Article 19(1) PCT and, as the case may be, the accompanying letter under Rule 46.5(b) PCT, the amendments under Article 19 PCT will be disregarded for the further proceedings. If only the statement under Article 19(1) PCT is not available in an official language, only that document will be disregarded. If the translation of the accompanying letter under Rule 46.5(b) PCT is not filed in time, the EPO will disregard that letter and may proceed under Rule 137(4) EPC where applicable.

any published request for rectification 

any sequence listing, unless the text in the sequence listing is available to the EPO in English (see point 5.6.010); where text matter in a sequence listing must be translated, the complete sequence listing complying with WIPO standard ST.25, including the translated text matter, must be submitted.

any separately furnished references to deposited biological material (Form 1200, Section 8).